Analyse produit facultative
Avec votre autorisation, nous utilisons une analyse limitée et respectueuse de la vie privée pour comprendre les parcours de recherche utiles. Nous n’utilisons ni traceurs publicitaires ni enregistrement de session. Vous pouvez modifier ce choix dans les préférences. Consultez la Politique de confidentialité.
Warner Bros. Discovery Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $77.6B | |
|---|---|---|
| P/E (forward) | 434.8x |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $12.19B | $33.82B | $41.32B | $39.32B | $37.30B | +32.3% |
| Gross profit | $7.57B | $13.38B | $16.80B | $16.35B | $10.51B | +8.5% |
| Operating income | $2.01B | $-7.37B | $-1.55B | $-10.03B | $738.0M | -22.2% |
| Net income | $1.01B | $-7.37B | $-3.13B | $-11.31B | $727.0M | -7.8% |
| EPS (diluted) | $1.54 | $-3.82 | $-1.28 | $-4.62 | $0.29 | -34.1% |
| EBITDA | $7.15B | $14.17B | $22.37B | $11.61B | $9.42B | +7.1% |
| R&D | — | — | — | — | — | — |
| SG&A | $4.02B | $9.68B | $9.70B | $9.30B | $9.42B | +23.7% |
Recent company headlines from major financial publishers.
The modal expected path reflects gradual turnaround execution. Linear networks contract moderately (-2.96% revenue contraction in FY2026 to $36.19B), offset by studio production ramping to 19 films in FY2027 which lifts consolidated revenue +3.12% to $37.32B. Operating margin expands from the 1.98% baseline in FY2025 toward normalized double-digit profitability. Robust annual free cash flow is systematically deployed to retire debt from the $32.02B base.
Under the bull scenario, the Studio segment cleanly executes on its 19-film release slate in FY2027, delivering multiple box office hits that accelerate Studio adjusted EBITDA past management's $3B target. International Max expansion in Europe outpaces linear cord-cutting, lifting consolidated FY2027 revenue toward the consensus high of $39.14B. Annual free cash flow expands substantially, accelerating balance-sheet deleveraging and compressing the enterprise cost of capital.
| Ke ↓ / g → | 1.5% | 1.8% | 2.0% | 2.3% | 2.5% |
|---|---|---|---|---|---|
| 9.5% | $24.1 | $24.1 | $24.1 | $24.1 | $24.1 |
| 10.0% | $24.1 | $24.1 | $24.1 | $24.1 | $24.1 |
| 10.5% | $24.1 | $24.1 | $24.1 | $24.1 | $24.1 |
| 11.0% | $24.1 | $24.1 | $24.1 | $24.1 | $24.1 |
| 11.5% | $24.1 | $24.1 | $24.1 | $24.1 | $24.1 |
Upcoming earnings date and setup when available.
La notation portée par l'édition de recherche publiée chaque mois. Une notation compare le cours à la date d'analyse à la juste valeur ; elle n'indique pas si l'appréciation s'est révélée juste.
| Année | janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
